Document Detail


Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats.
MedLine Citation:
PMID:  8258956     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypercholesterolemia frequently accompanies the nephrotic syndrome, but the mechanism responsible for elevation of plasma cholesterol is poorly understood. Specifically, the contribution of abnormal hepatic cholesterol metabolism to elevated concentrations of serum cholesterol has never been studied in depth. The objective of the present study was to define the alteration of hepatic cholesterol metabolism in puromycin induced nephrotic syndrome in rats. Studies involved measurements of specific activities of four enzymes participating in the maintenance of hepatic cholesterol metabolism: HMG-CoA-reductase, the rate limiting enzyme of cholesterol synthesis; cholesterol 7 alpha-hydroxylase, the rate limiting enzyme in bile acid synthesis; acyl CoA: cholesterol acyltransferase, the enzyme responsible for esterification of cholesterol; and cholesterol ester hydrolase (CEH), an enzyme which hydrolyzes cholesterol. Multiple injections of puromycin resulted in a production of nephrotic syndrome with massive proteinuria, hypoalbuminemia, hypercholesterolemia, ascites and edema. HMG-CoA-reductase (nmol/hr/mg protein) and cholesterol 7 alpha-hydroxylase activities (nmol/hr/mg protein) in rats with nephrotic syndrome were not statistically significant as compared to control rats (4.0 +/- 0.7 and 2.0 +/- 0.6 vs. 3.3 +/- 0.4 and 1.6 +/- 0.2), respectively. Our results also demonstrate, for the first time, that the normal diurnal rhythm in HMG-CoA reductase activity is no longer present in the nephrotic animals. The activities in the nephrotics in the day was 4.0 nmol/hr/mg and at night, 3.9 nmol/hr/day, compared to the control values of 3.3 nmol/hr/mg in the day and 6.9 nmol/hr/mg at night. ACAT activities were 428 +/- 78 versus 302 +/- 64 pmol/min/mg/protein (P = NS).(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
M A Thabet; A Challa; J C Chan; W M Pandak; D M Heuman; Z R Vlahcevic
Related Documents :
1270936 - Sterol balance in hyperlipidemic patients after dietary exchange of carbohydrate for fat.
12954916 - Behavioral implications of lowering cholesterol levels: a double-blind pilot study.
19435556 - Effects of urtica dioica extract on lipid profile in hypercholesterolemic rats.
7734446 - Regulation of hepatic cholesterol metabolism in the rat in vivo: effect of a synthetic ...
8992606 - Metabolic and morphometric changes in small and large intestine in rats fed high-fiber ...
11010936 - Energy metabolism after 2 y of energy restriction: the biosphere 2 experiment.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Kidney international     Volume:  44     ISSN:  0085-2538     ISO Abbreviation:  Kidney Int.     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1994-01-19     Completed Date:  1994-01-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  789-94     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Children's Medical Center, Medical College of Virginia, Richmond.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cholesterol / metabolism*
Cholesterol 7-alpha-Hydroxylase / metabolism
Circadian Rhythm
Female
Hydroxymethylglutaryl CoA Reductases / metabolism
Liver / metabolism*,  ultrastructure
Nephrotic Syndrome / chemically induced,  enzymology,  metabolism*
Puromycin
Rats
Rats, Sprague-Dawley
Sterol Esterase / metabolism
Sterol O-Acyltransferase / metabolism
Grant Support
ID/Acronym/Agency:
DK 07526/DK/NIDDK NIH HHS; DK 31370/DK/NIDDK NIH HHS; P01 DK 38030-06/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
53-79-2/Puromycin; 57-88-5/Cholesterol; EC 1.1.1.-/Hydroxymethylglutaryl CoA Reductases; EC 1.14.13.17/Cholesterol 7-alpha-Hydroxylase; EC 2.3.1.26/Sterol O-Acyltransferase; EC 3.1.1.13/Sterol Esterase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interstitial fibrosis in obstructive nephropathy.
Next Document:  In situ expression of cytokines in IgA nephritis.